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Introduction
The existence of mercury has been known
for a very long time. It is now widely used in
many ways in industry and in medicine. Mer-
cury exists in three forms: elemental mer-
cury (Hg0), inorganic mercury (Hg+, Hg2+),
and organic mercury (CH3Hg+). The
sources, pharmacokinetics and biological
effects of these forms can vary. Elemental
and inorganic mercury toxicity can result
from industrial exposure, i.e. gold extraction
processes (1), commercial application in sci-
entific instruments and equipment (2), and
production of caustic soda and button (disc)
batteries (3). Organic mercury toxicity poi-
soning can result from methyl mercury pes-
ticides (4), the burning of coal and other
fossil fuels (5), or mining, smelting and refin-
ing processes. Mercury and mercury com-
pounds can be washed from solid waste into
lakes and streams, where micro-organisms
transform them into their inorganic form,
methyl mercury. This is then consumed and
concentrated up the food chain, ultimately
poisoning birds and mammals — including
humans — that eat, for example, poisoned
fish (6). Mercury pollution has now reached
crisis proportions, especially in developed
countries (7).
The main pathway of chronic mercury poi-
soning in Latvia is via the mouth and respi-
ratory system. Toxic mercury vapours are
released by its alloys (amalgams). Amalgams
of tin and silver are widely used in dentistry
(8). According to data provided by the Statis-
tical Board of Latvia, 1794 medical workers
were employed in dentistry in 1998 (9). Of
these, 55% used unprotected composite
material from amalgams, and were therefore
exposed to the effects of mercury vapours.
Physicians also administer mercury, for
example, as anti-syphilitic remedies and
mercurial diuretics, to treat medical prob-
lems (10, 11).
Mercury is absorbed in varying amounts
when it is taken into the human body via
air, water or food. It accumulates in the
liver, kidneys, brain and blood, and can
cause both acute and chronic health prob-
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lems, depending on the form of mercury
involved (11).
The Multicenter Evaluation of In Vitro
Cytotoxicity (MEIC) programme was set up
to evaluate the relevance of in vitro cytotoxi-
city tests in predicting acute human systemic
toxicity. By the end of the programme in
1996, 29 laboratories had tested 50 chemi-
cals, including mercury chloride, in 61 cyto-
toxicity assays (12). The toxicity of mercury
chloride was evaluated in vitro by using a
variety of cell cultures, including cultures of
keratinocytes, hepatocytes and neurons (13).
The aim of this study was to assess the in
vitro toxicity of mercury by using a
hybridoma cell culture, which had never pre-
viously been used for the evaluation of mer-
cury compound toxicity, even though
hybridoma technology has existed since 1975
(14). This model could solve many of the
problems encountered in immunology and
medicine in assessing the many factors
which can harm the human body.
Materials and Methods
An established hybridoma cell line, TA7, was used.
TA7 is derived from the hybridisation of myeloma
Sp2/0 cells with immune spleen lymphocytes from
Balb/c mice (Stolbovaja arboretum, Russia), and
produces anitbodies against the A-subunit of
viskulin (15). Hybridomas were clonally trans-
formed by using the limit dissolution method.
Hybridoma TA7 cells have been used for experi-
mental oncology research at the Moscow State
University. Our colleagues there kindly donated
the hybridomas for use in our experiments.
For the maintenance of stock cultures,
hybridoma TA7 cells were seeded at a density of
10,000 cells/25cm2 flask, on a feeder layer of fresh
spleen cells from Balb/c mice, and in 30ml RPMI-
1640 medium (Sigma, St Louis, MO, USA), sup-
plemented with 10% fetal calf serum.
For the experiments, 50,000 hybridoma TA7
cells were seeded in each well of a 96-well flat-bot-
tomed plate, in RPMI-1640 medium with 10% fetal
calf serum. The cells were exposed to 0.1nM/l–
10µM/l Hg(NO3)2.2H2O (mercury nitrate) for 48
hours at 37°C in 5% CO2/95% air.
The MTT assay (16) was used to evaluate the
viability of the TA7 cells. Briefly, a stock solution
of 5mg/ml MTT (Sigma) was made. The culture
medium was removed from the wells of the 96-well
plates and replaced with 100µl RPMI-1640 con-
taining 0.5mg/ml MTT. After incubation for 3
hours at 37°C and then for 30 minutes at 4°C, the
plates were centrifuged at 3300g for 20 minutes at
4°C. The supernatant was removed from each well,
then 200µl 100% dimethyl sulphoxide was added
to each well, followed by a further incubation for
10 minutes at 37°C. Colorimetric measurements
were then made in a Multiwell spectrophotometer
(ELISA reader) by using a Labsystems Multi-
skan® Plus (Finland) at a wavelength of 540nm,
and the results for test wells were expressed as a
percentage of the untreated control well values.
The TA7 hybridoma cells in our case were not
used as a model of immunotoxicology, but as a
novel approach for mercury toxicity monitoring.
This work was performed after previous experi-
ments with mercury compounds, by using meth-
ods we have developed to assess the  toxicities of
ecological pollutants (17). These experiments
included the culture of chick embryo macrophages
tested with the same concentrations of mercury
nitrate as those used in the present study.
Statistical analyses were performed by using
electronic tables in Excel 5.0 for Windows and
commonly used methods for parametric variation
and correlation statistics.
Results
The toxic dose-effect of mercury on
hybridoma TA7 cells was studied in two
series of tests. Table I shows the results of
the two series of experiments, and the sup-
posed standard control exponential values
between the maximal and minimal means
(0.1nM/l–10µM/l) for the data. The first
series data concern an earlier experiment
and was worked out from only three tests.
Therefore, they have comparatively large
standard deviations (SDs). The second series
data are based on 12 tests and are closer to
the control exponential values. No reliable
distinctions between indices of cell survival
in the range of concentrations of mercury
0.1nM/l–0.1µM/l were found in the first
series, but the means of cell survival with
concentrations 0.1–10µM/l were statistically
significant (p < 0.05) in the second series.
The correlation indices of the dose-effect
data of all the experimental data were r2 =
0.95 in the first series and r2 = 0.93 in the
second series. In the range 0.1nM/l–0.1µM/l
of the experimental data, they were r2 = 0.07
in the first series and r2 = 0.91 in the second
series. In the range 0.1–10µM/l of the exper-
imental data, they were r2 = 0.98 and r2 =
0.99 accordingly. Therefore, concentrations
between 0.1nM/l and 0.1µM/l can be consid-
ered as the no-effect level, and 0.1–10µM/l as
the observed effect level (consisting of
0.1–1µM/l as the lowest observed effect level,
1–10µM/l as the highest effect level, and >
10µM/l as the 100% lethal concentration) in
hybridoma TA7 cells.
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The percentage indices (mean ± SD) of cell
survival in chick embryo macrophage cul-
tures exposed to mercury nitrate were 96 ±
11% (0.1nM/l), 94 ± 10% (1nM/l), 89 ± 9%
(10nM/l), 84 ± 7% (0.1µM/l), 61 ± 8%
(1µM/l) and 0% (10µM/l; 17). Statistically dif-
ferent data (p < 0.05) from the control data
were found for concentrations between
1µM/l and 10µM/l mercury nitrate. The cor-
relation between indices of mercury nitrate
toxicity in hybridoma TA7 cells and chick
embryo macrophage models was r2 = 0.98.
Discussion
One of the main topics in modern toxicology
is the search for new predictive tests (18),
and particularly in vitro tests, taking into
account the desire to replace animal experi-
mentation (12, 13). At a workshop held in
1998, which was devoted to discussing the
scientific and regulatory challenges for the
reduction, refinement and replacement of
animals in medical testing, a variety of cell
culture systems, including those involving
hybridomas, were highlighted (19)
Haitov et al. (14) discussed the value of
hybridoma systems prepared by many differ-
ent technologies for studies of proliferative,
cytostatic and degenerative processes under
the influence of different agents, including
toxic agents. Moreover, hybridomas based on
myelomas represent processes predomi-
nantly found in antibody-synthesising B-
cells, while using myelomas with T-cell
clones could permit hybridoma systems to be
developed, which would display immunologi-
cal processes such as T-cell cytokine activity.
Ig-synthesis by B53 hybridoma cells was
demonstrated in the work of Setum &
Mathur (20). A human T-cell hybridoma was
developed from T-cells of an individual aller-
gic to honey bee venom, which produced an
antigen-binding glycosylation inhibition fac-
tor having affinity for bee venom (21, 22).
Also, a human T-T cell hybridoma produces
a T-cell-derived supressor factor (23). It is
important to stress that in the “New Meth-
ods and Models” section of an issue of one of
the leading toxicological periodicals, Toxicol-
ogy in Vitro, the use of the MCF-7-E3 cell
proliferation assay for environmental pollu-
tants and industrial chemicals (24), and also
for the effects of potential oestrogens and
non-oestrogenic substances (25, 26), was pos-
itively evaluated. The CFD-PBPK hybrid
model for simulating gas and vapour uptake
in the rat nose is also very useful (27).
Original cytotoxicity experiments on mer-
cury with the TA7 hybridoma model can be
substantiated by considering the results
obtained in the light of the usefulness of
hybridoma models for the cytotoxicity evalu-
ation of various environmental, industrial or
other agents. Another novel aspect of the
toxicological experiments with mercury was
the use of the MTT reduction assay for the
quantification of the cytotoxic effects of mer-
cury and their concentration limits. With
this convenient test, we have measured the
100% lethal concentration, and the highest
and the lowest cytotoxic levels of mercury
nitrate for the TA7 hybridoma cells. Keisari
(28) and Chiba et al. (29) stress the validity
of the MTT assay as a useful and convenient
Table I: The cytotoxic dose-effect of mercury (Hg2[NO3]2.2H2O) on hybridoma
TA7 cells in percentage survival of cells
Percentage survival (mean ± SD)
0.1nM/l 1nM/l 10nM/l 0.1µM/l 1µM/l 10µM/l 
Experiment mercury mercury mercury mercury mercury mercury
First series 103 ± 15 92 ± 9 84 ± 7 90 ± 10 69 ± 6 0 ± 0.1
Second series 100 ± 9 96 ± 6 90 ± 5 88 ± 6 65 ± 5 0*
Control 100 97.4 94.8 86.9 63.4* 0*
*p < 0.05 compared to data produced after exposure to 0.1nM/ml–0.1µM/ml
colorimetric test for cellular growth and via-
bility, which is valuable for the testing of
various types of agents.
The relevance of the TA7 cell model is con-
nected with its high rate of replication, and
its high sensitivity to such cytotoxic agents
as mercury nitrate.
Conclusions
The original data about mercury compound
Hg2(NO3)2.2H2O toxicity in vitro on
hybridoma TA7 cell cultures supports the
usefulness, sensitivity and reproducibility of
this testing approach. The colorimetric MTT
assay is a convenient and useful assay for
quantification of the cytotoxic effects of mer-
cury nitrate on hybridoma TA7 cells. By
using this methodological approach, the low-
est and highest effect levels and the 100%
lethal concentration to hybridoma TA7 cells
for the mercury compound was measured.
This data suggest that hybridoma TA7 cells
might be useful in assessing the dose-effect
in in vitro toxicological experiments.
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